
Madison Muller
Health Reporter at Bloomberg News
Health reporter for @business in New York | Email: [email protected] | Chicagoan at heart
Articles
-
1 week ago |
wyomingnews.com | Madison Muller
State AlabamaAlaskaArizonaArkansasCaliforniaColoradoConnecticutDelawareFloridaGeorgiaHawaiiIdahoIllinoisIndianaIowaKansasKentuckyLouisianaMaineMarylandMassachusettsMichiganMinnesotaMississippiMissouriMontanaNebraskaNevadaNew HampshireNew JerseyNew MexicoNew YorkNorth CarolinaNorth DakotaOhioOklahomaOregonPennsylvaniaRhode IslandSouth CarolinaSouth DakotaTennesseeTexasUtahVermontVirginiaWashingtonWashington D.C.West VirginiaWisconsinWyomingPuerto RicoUS Virgin IslandsArmed Forces AmericasArmed...
-
1 week ago |
dailygazette.com | Madison Muller
U.S. health officials are terminating a $590 million contract with Moderna Inc. to develop vaccines for bird flu, a major setback for the company that’s also facing additional government scrutiny over immunizations. Moderna said in a statement Wednesday that the vaccine was shown to be safe and well-tolerated in early clinical studies.
-
1 week ago |
news.bloombergtax.com | Madison Muller |Gerry Smith
XYour Choices Regarding Cookies and IdentifiersWe and our 150 third party partners use cookies and similar technologies ("Cookies") and hashed identifiers (e.g., a hashed version of your name, email address or phone number) to help us identify you on our site and third-party sites and to process certain information, such as your IP address and digital identifiers, to analyze site usage and provide you with relevant advertisements and content.
-
1 week ago |
news.bloomberglaw.com | Madison Muller |Gerry Smith
US health officials are terminating a contract with Moderna Inc. worth up to $766 million to develop vaccines for bird flu, a major setback for the company as it faces additional government scrutiny over immunizations. Moderna said in a statement Wednesday that the vaccine was shown to be safe and well-tolerated in early clinical studies.
-
1 week ago |
thederrick.com | Madison Muller
U.S. health officials are terminating a $590 million contract with Moderna Inc. to develop vaccines for bird flu, a major setback for the company that’s also facing additional government scrutiny over immunizations. Moderna said in a statement Wednesday that the vaccine was shown to be safe and well-tolerated in early clinical studies.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →X (formerly Twitter)
- Followers
- 5K
- Tweets
- 12K
- DMs Open
- Yes

Scoop with @josh_wingrove: The White House is pulling its nomination for Janette Nesheiwat to be US surgeon general. This is the second high-profile health nominee the WH has pulled just before they were due to appear in front of a Senate panel. https://t.co/FWxnzw9n8I

RT @josh_wingrove: New: The White House is said to be pulling its nomination of Janette Nesheiwat as Surgeon General, per sources. Story on…

RT @AnjKhem: $LLY CEO David Ricks on $CVS/ $NVO formulary deal: "It feels a little bit like last decade, these...lock-up deals. We're not…